Sarah Bailey’s Post

Have you signed up for tomorrow's 60-minute masterclass, Market Access NHS England In conversation with Neil Grubert? Key Learning Objectives: 🗣️ What does Neil think will be the key drivers of access success for the remainder of 2024 and beyond? 🗣️ What access barriers will you need to overcome ? 🗣️ What is the outlook for access and how does pharma and medtech need to respond post the General Election? Can't make it tomorrow? Register and we'll send you a link to the recording so you can watch it on demand in your own time. #nhs #lsaa #lifesciences #pharma #medtech #marketaccess #HealthcareStrategy #UKPolitics #AccessBarriers #Election2024 #HealthPolicy #StakeholderEngagement #HealthcareMasterclass LSAA Members register here: https://lnkd.in/edXyisCJ 🎙️Connect with us! Speaker: Neil Grubert Host: Ian Chamberlain To see our other masterclasses, go to our website: https://lnkd.in/eVJWfGih

Today’s 37th Workshop of the #EURORDIS Round Table of Companies saw over 130 registrants, representing 19 countries, gather to discuss the importance of transforming foresight into action to support the development of affordable and accessible treatments for rare diseases patients! 🗣️ Here are the key learnings: - Early dialogues between patients, regulators, HTA bodies, payers, and developers are key to fostering innovation. Check out our recommendation for an orphan drug development plan: https://lnkd.in/eSQWhn9Z - Mechanisms such as PRIME and MoCA are important examples of these collaborations but trust must remain at the heart of these relationships in order to foster the type of changes we want to see. - To overcome global healthcare challenges and reach the goal of 1000 new treatments by 2030, we as a community must continue to drive change and turn good will into action. Transparent public-private relationships between patient advocates, industry, academia and decision makers are essential to shape policies that best serve the interests of our community. Learn more about the ERTC on our website. Tomasz Grybek, Kevin Loth #collaboration #industry #relationships #workshop #cooperation #meeting

Have you signed up for tomorrow's 60-minute masterclass, Market Access NHS England In conversation with Neil Grubert? Key Learning Objectives: 🗣️ What does Neil think will be the key drivers of access success for the remainder of 2024 and beyond? 🗣️ What access barriers will you need to overcome ? 🗣️ What is the outlook for access and how does pharma and medtech need to respond post the General Election? Can't make it tomorrow? Register and we'll send you a link to the recording so you can watch it on demand in your own time. #nhs #lsaa #lifesciences #pharma #medtech #marketaccess #HealthcareStrategy #UKPolitics #AccessBarriers #Election2024 #HealthPolicy #StakeholderEngagement #HealthcareMasterclass LSAA Members register here: https://lnkd.in/e8RpE5Vx To see our other masterclasses, go to our website: https://lnkd.in/eA2xCDdy

Donna O'Brien, Manatt Health, Trevan Locke, Duke-Margolis and Dr Denise Snyder, Duke University School of Medicine will discuss Financial Barriers: Getting More Coverage for Patients in Clinical Trials at the #CRAACO2024 conference. More specifically they will address: - Identifying financial barriers to get coverage for clinical trials - Coverage by sponsors vs standard of care - What policy approaches can empower hospitals, trial sponsors, providers, and other stakeholders to manage change with their own organizations and engage with payers to foster broader coverage of trial-related activities - How we can improve evidence generation processes within our own organizations for both healthcare systems and pharma - And More Learn more at https://craacoevent.com/ #ClinicalResearch #ClinicalTrials #FinancialBarriers #hospitals #pharma #conference

We are running an industry round table to explore how pharmaceutical and life science companies can best serve HCPs to deliver compassionate and comprehensive patient care. So, if you are passionate about evolving patient journeys and HCP customer experience then sign up to join the discussion below. #HCP #pharma #patients #patientcentricity #healthcare

At Baringa, we're on a mission to transform how patients are treated throughout their patient journey and, in doing so, help the very people who are closest to delivering this: their HCPs. Healthcare has changed astronomically in the past decade. From empowered patients, digital health, an ever-bludgeoning set of healthcare systems, new disruptive healthcare entrants, and an increasing eye on value and equity of access, there are a plethora of challenges for our pharmaceutical and life science clients. We're hosting a series of virtual round tables for colleagues from across the pharmaceutical and healthcare industry to share ideas and come up with practical solutions to these challenges. We'll also bring in Baringa experts from outside the industry to showcase the art of the possible. Join our inaugural virtual round table on Wednesday 17 April 2024, 14:00-15:30 UKT, where we'll be looking at how we can best serve HCPs to deliver compassionate and comprehensive patient care, as their time and capacity to speak to and connect with patients decreases. Register here for our inaugural virtual round table > https://ow.ly/lAwA50QR6HV Delegate numbers are limited, to encourage open discussion, so register your place now. #HCP #pharma #healthcare #patients #patientcare

Photo highlights from the IASPHARMA 2023 Day 2 Breakout Forums It has been a fascinating combination of enlightening conversations, well-rounded speakers and thought leaders, and very intelligent participants. We are learning that the movement to bring about the realization of clinical trials in Africa represents a significant step toward addressing healthcare disparities and advancing medical knowledge for the benefit of all. #IASPHARMA2023 #Clinicaltrials #Clinicaltrialssummit

In the latest featured webinar hear a discussion of the unique challenges and solutions that are opportunities for collaboration to work together to create better and safer medicines for all patients while it's still open access: https://bit.ly/2CfFiDi

With so many well-informed discussions being held on the application of AI in the healthcare Industry, I’m finding it interesting to read about the various perspectives that are coming from corporate leaders and specialists within the field - amongst other thoughts - here are 3 key takeaways on AI vs. Human touch from Lynxeye

After visiting the Future of Health & Healthcare and e-Health conference (Framtidens Hälso & Sjukvård and e-Hälsa+MVTe), I think the conversations on AI were a lot more nuanced than they have been in the last couple of years - perhaps a sign of us entering the next phase of the Hype Cycle? Read some of our key takeaways in the post below!